HOME >> MEDICINE >> NEWS
Experts present new research on the hot topics of aging at GSA's Annual Meeting

Note to Editors: The Gerontological Society of America will host its 2003 Annual Scientific Meeting in San Diego, CA, November 21-25. The following is a sampling of the more than 400 sessions scheduled for the five-day conference. Dates and times of the sessions described are in italics. Members of the press may register and customize their own schedule by visiting http://www.eshow2000.com/geron/about_the_meeting.cfm.

Increasing Life Expectancy: The subject of anti-aging is perhaps the most publicly sought-after gerontology news topic today. How far can science extend the human lifespan? This question is due to be answered during one of the over 400 presentations at The Gerontological Society of America's annual meeting. The particular matter of human longevity will be addressed during a symposium consisting of four 20-minute talks, including presentations from biologists Leonard Hayflick and Caleb Finch and demographers James Vaupel and James Carey. They are slated to present the GSA audience with hard, baseline information about current U.S. and worldwide trends in life expectancy and life span, as well as a synopsis of recent developments and/or breakthroughs in the biology of aging.
November 24 at 3:30 p.m.

The Fountain of Youth: The seriousness of the aforementioned extension of the human lifespan will be tackled in GSA's Public Policy Committee symposium, titled "The Genie's Out of the Bottle: Moral, Ethical, and Societal Implications of the Search for the Fountain of Youth." It begins with a review of the great strides that biological research on aging has made in the last two decades, and the possibility of a drug for life-extensions. Next it presents a humanistic exploration of whether decelerating or arresting aging would be an assault on human dignity. Then it considers the professional ethical issues that effective anti-aging
'"/>

Contact: Todd Kluss
tkluss@geron.org
202-842-1275
The Gerontological Society of America
24-Sep-2003


Page: 1 2 3 4

Related medicine news :

1. Experts debate benefits, dangers of chlorine in C&EN point-counterpoint
2. Experts to discuss new advances in IBS therapy and its affect on IBS sufferers
3. Experts to discuss emerging technologies in GI diagnosis and treatment
4. Experts to discuss the affects of non-steroidal anti-inflammatory drugs (NSAIDs)
5. Experts welcome major reforms to the coroners service
6. Experts meet to challenge approaches of testing and developing cancer treatments
7. Experts highlight cardiovascular and drug interaction risks in elderly patients
8. Experts gathering to discuss tapping into $40-$50 billion natural products market
9. Experts recommend increased funding, focus on resuscitation science
10. Experts announce global antimicrobial resistance initiative - World preview of the Global White Paper on bacterial resistance in respiratory tract infections - a call for concerted international action
11. Heart Experts Call For Action Against Missed Opportunities To Prevent Heart Disease In Women

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Experts present new research the hot topics aging GSA Annual Meeting

(Date:8/20/2014)... 20, 2014 BCC Research ( ... PHOTONIC SENSORS AND DETECTORS: TECHNOLOGIES AND GLOBAL MARKETS ... is expected to grow to $15.2 billion by ... (CAGR) of 15.9%. Increasing industrialization is driving ... a rapidly expanding range of industrial applications such ...
(Date:8/20/2014)... A Missouri federal judge has remanded a lawsuit filed ... GranuFlo and NaturaLyte to the City of St. Louis Circuit ... The judge rejected an assertion by the defendants that the ... et al. v. Fresenius Medical Care North America Inc., et ... the manufacturer of the dialysis products GranuFlo and NaturaLyte. In ...
(Date:8/20/2014)... (HealthDay News) -- Leaving the car at home and getting ... for your health, a new study indicates. Researchers looked ... that 76 percent of men and 72 percent of women ... of women used public transit, and 14 percent of men ... who drove to work weighed more and had higher levels ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 The ... leading nonprofit authority on the use of health ... announced the full agenda for its annual fall ... IT Efficiency. WEDI-Con 2014 will take place at ... 20-23, 2014, attracting a diverse cross-section of payers, ...
(Date:8/20/2014)... Parents and kids across the nation are ... means buying textbooks and arranging after school care, there ... part of the annual re-commitment to your child’s education; ... Association, 27% of students say they experience "extreme stress" ... are stressed by school pressures. The study, Stress in ...
Breaking Medicine News(10 mins):Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 2Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 3Health News:GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports 2Health News:Want to Stay Slim? Leave the Car at Home 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 3Health News:Five Easy Steps to Help Your Child Manage Back-to-school Stress 2Health News:Five Easy Steps to Help Your Child Manage Back-to-school Stress 3
(Date:8/19/2014)... , Aug. 19, 2014  Boehringer Ingelheim today ... (FDA) accepted for review the New Drug Application ... and olodaterol delivered via the Respimat ® ... maintenance treatment of airflow obstruction in patients with ... and/or emphysema. Tiotropium + olodaterol FDC will not ...
(Date:8/19/2014)... -- According to Kalorama Information, electronic medical records (EMR) ... in healthcare a reality, and this a factor that ... Recovery and Reinvestment Act, the U.S. government dedicated $20.6 ... will start applying soon for use of paper records.  ... of the EMR industry, EMR 2014: The Market ...
(Date:8/19/2014)... Calif. , Aug. 19, 2014  Cardiva Medical, ... two tranches of a $16.5 million Series 3 private ... with GE Capital. The Company will use the proceeds ... facility to expand commercial efforts for its VASCADE® Vascular ... . Investing in Series 3 private ...
Breaking Medicine Technology:Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2
Cached News: